92 participants
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2013-06-30
- Completion:
- 2027-06-30
Conditions
- Germ Cell Tumors
Interventions
- DRUG
No Results Yet